{"id":"W4366771615","doi":"10.3389/fphar.2023.1101063","title":"Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Apatinib; Medicine; Sorafenib; Jadad scale; Internal medicine; Funnel plot; Publication bias; Meta-analysis; Placebo; Oncology; Randomized controlled trial; Adverse effect; Hepatocellular carcinoma; Cancer; Surgery; Cochrane Library; Pathology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01493335,0.002900535,0.02187851,0.006258291,0.0006709523,0.003259675,0.002248914,0.00249583,0.0033762],"category_scores_gemma":[0.03045307,0.001316166,0.04672279,0.006367902,0.0006785428,0.001746572,0.001270802,0.001805695,0.00029256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003063517,"about_ca_system_score_gemma":0.003741696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005172946,"about_ca_topic_score_gemma":0.01063372,"domain_scores_codex":[0.9887877,0.005417634,0.003201862,0.001049062,0.001227663,0.0003161065],"domain_scores_gemma":[0.9831308,0.01201775,0.0028365,0.0004612864,0.001325938,0.0002276479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002514065,0.00003830199,0.002267479,0.355106,0.6295341,0.0001105872,0.00006751595,0.0005544421,0.0002097592,0.0001237755,0.0004174318,0.009056597],"study_design_scores_gemma":[0.0005985145,0.0002348296,0.001967658,0.01834046,0.9773008,0.00007913983,0.00003058813,0.0001960277,0.0001057303,0.0001546973,0.0009724759,0.00001896822],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004893486,0.9932677,0.000504367,0.0001989355,0.0001313941,0.0003519995,0.0004117765,0.00002141722,0.0002190011],"genre_scores_gemma":[0.2190129,0.7726337,0.00303132,0.001188816,0.0003789755,0.002130885,0.00113175,0.00004036504,0.0004514636],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02187851,"threshold_uncertainty_score":0.07897604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1796366256034435,"score_gpt":0.3936292491979095,"score_spread":0.213992623594466,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}